Yield10 Bioscience, Inc. announced that it has entered into a non-binding Letter of Intent with new investor Marathon Petroleum Corporation for a private placement of senior unsecured convertible promissory note for gross proceeds of $1 million on May 1, 2023. The notes are convertible into common shares of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
182.8 USD | +0.13% | -8.84% | +23.20% |
05-06 | UBS Adjusts Marathon Petroleum Price Target to $232 From $249, Maintains Buy Rating | MT |
05-06 | Jefferies Cuts Price Target on Marathon Petroleum to $217 From $221 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.20% | 64.32B | |
+9.83% | 233B | |
+9.49% | 105B | |
+17.36% | 100B | |
+9.00% | 60.88B | |
+21.69% | 51.29B | |
+25.42% | 36.46B | |
+28.03% | 28.2B | |
-11.40% | 21.15B | |
+7.77% | 18.84B |
- Stock Market
- Equities
- MPC Stock
- News Marathon Petroleum Corporation
- Yield10 Bioscience, Inc. announced that it expects to receive $1 million in funding from Marathon Petroleum Corporation